BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 17383509)

  • 21. [Facial anatomy and botulinum toxin: the muscular balances].
    Trevidic P; Cauchois R; Ingallina F
    Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S61-6. PubMed ID: 19576487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Persistence of the synaptosomal-associated protein-25 cleavage product after intradetrusor botulinum toxin A injections in patients with myelomeningocele showing an inadequate response to treatment.
    Schulte-Baukloh H; Zurawski TH; Knispel HH; Miller K; Haferkamp A; Dolly JO
    BJU Int; 2007 Nov; 100(5):1075-80. PubMed ID: 17784887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prevention and management of locoregional complications of botulinum A toxin injections in cosmetic treatment].
    Gassia V
    Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S146-51. PubMed ID: 19576482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Noninvasive techniques in periorbital rejuvenation.
    Glavas IP; Purewal BK
    Facial Plast Surg; 2007 Aug; 23(3):162-7. PubMed ID: 17691063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of muscular contraction deformities with botulinum toxin type A after latissimus dorsi flap and sub-pectoral implant breast reconstruction.
    Figus A; Mazzocchi M; Dessy LA; Curinga G; Scuderi N
    J Plast Reconstr Aesthet Surg; 2009 Jul; 62(7):869-75. PubMed ID: 18411075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Botulinum Toxin Type A in the treatment of chronic migraine without medication overuse.
    Freitag FG; Diamond S; Diamond M; Urban G
    Headache; 2008 Feb; 48(2):201-9. PubMed ID: 18042229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term clinical outcome after botulinum toxin injection in children with nonrelaxing internal anal sphincter.
    Chumpitazi BP; Fishman SJ; Nurko S
    Am J Gastroenterol; 2009 Apr; 104(4):976-83. PubMed ID: 19259081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autologous fat transfer for periorbital rejuvenation: indications, technique, and complications.
    Kranendonk S; Obagi S
    Dermatol Surg; 2007 May; 33(5):572-8. PubMed ID: 17451580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of botulinum toxin A on the survival of a random cutaneous flap.
    Kim TK; Oh EJ; Chung JY; Park JW; Cho BC; Chung HY
    J Plast Reconstr Aesthet Surg; 2009 Jul; 62(7):906-13. PubMed ID: 18436495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. From frown lines to fissures: therapeutic uses for botulinum toxin.
    Sutcliffe RP; Sandiford NA; Khawaja HT
    Int J Surg; 2005; 3(2):141-6. PubMed ID: 17462275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Botox: beyond cosmetic fixes. The procedure that revolutionized wrinkle treatment has myriad medical uses, many still experimental. What's the evidence?
    Harv Womens Health Watch; 2009 Sep; 17(1):1-3. PubMed ID: 19928628
    [No Abstract]   [Full Text] [Related]  

  • 32. Botox Therapy in Dentistry: A Review.
    Azam A; Manchanda S; Thotapalli S; Kotha SB
    J Int Oral Health; 2015; 7(Suppl 2):103-5. PubMed ID: 26668495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rejuvenation of the periorbital complex with autologous fat transfer: current therapy.
    Ciuci PM; Obagi S
    J Oral Maxillofac Surg; 2008 Aug; 66(8):1686-93. PubMed ID: 18634958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BOTOX cosmetic for lip and perioral enhancement.
    Gordon RW
    Dent Today; 2009 May; 28(5):94-7. PubMed ID: 19485016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inguinal hyperhidrosis misdiagnosed as urinary incontinence: treatment with botulinum toxin A.
    Woolery-Lloyd H; Elsaie ML; Avashia N
    J Drugs Dermatol; 2008 Mar; 7(3):293-5. PubMed ID: 18380213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safe botulinum toxin type A injection in patients with history of eyelid ptosis.
    Ghalamkarpour F; Aghazadeh Y; Odabaei G
    J Cosmet Dermatol; 2009 Jun; 8(2):98-102. PubMed ID: 19527332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Facial rejuvenation with botulinum neurotoxin: an anatomical and experiential perspective.
    Fagien S; Raspaldo H
    J Cosmet Laser Ther; 2007; 9 Suppl 1():23-31. PubMed ID: 17885883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Botulinum toxin A adjunctive use in manual chemabrasion: controlled long-term study for treatment of upper perioral vertical wrinkles.
    Kadunc BV; Trindade DE Almeida AR; Vanti AA; DI Chiacchio N
    Dermatol Surg; 2007 Sep; 33(9):1066-72; discussion 1072. PubMed ID: 17760597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anatomy of the eyelids.
    Most SP; Mobley SR; Larrabee WF
    Facial Plast Surg Clin North Am; 2005 Nov; 13(4):487-92, v. PubMed ID: 16253835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.